Page 11 - BB Neuromedicine Highlights 2019
P. 11
cyte Pharmaceuticals could sion symptoms treatment alternative forms of inhaled
completely change current involves the company’s name- progesterone for the same
head trauma care. sake…the astrocyte. Astro- purpose. Depending on pend-
cytes are the brain’s caretaker ing drug trials, any of these
asTroCyTe pharma- cells that help repair injury agents may offer new hope for
CeuTiCals approaCh To and reduce inflammation. concussion symptoms treat-
ConCussion sympToms Astrocyte Pharmaceuticals ment. Moreover, Astrocyte
TreaTmenT has thus developed a small Pharmaceuticals’ drug may
In terms of Astrocyte Phar- molecular drug that stimulates simply be a part of a neuro-
maceuticals neuromedicine astrocytes to “do their thing.” medicine “cocktail” individuals
approach, their concussion By boosting astrocytes’ ener- receive after a head injury.
symptoms treatment is gy systems, their concussion Today, there is a growing
unique. When a concussion symptoms treatment hopes to recognition of chronic trau-
or brain injury occurs, several reduce the potential damage matic encephalopathy (CTE)
things can happen. Nerve brain injuries might cause. as a serious condition. CTE can
fibers may tear or twist from cause a number of problems
the impact itself. Inflammato- FuTure ConCussion for individuals including seri-
ry proteins and chemicals may SymptomS treatment – ous cognitive and emotional
flood an area and cause dam- a reCipe oF neuromed- disturbances. While prevention
age. These effects occur within iCines? remains a priority, it is also
seconds to hours after injury, Astrocyte Pharmaceuticals important for new concussion
and attempts to reduce these is part of a handful of compa- symptoms treatments to be
effects to date have been nies exploring new concussion developed as well. Hopefully,
ineffective. Ideally, a concus- symptoms treatments. For Astrocyte Pharmaceuticals and
sion symptoms treatment example, Oxeia, based in San other startups will soon offer
would be able to reduce these Diego, is testing Ghrelin as better options of care for those
harmful effects and promote a potential neuroprotective suffering from head injuries. As
healing immediately. agent in brain injury. Likewise, a result, many of the devastat-
For Astrocyte Pharmaceu- Prevacus, based in Tallahas- ing consequences often seen
ticals, their potential concus- see, is experimenting with can hopefully be avoided.